Cargando…

Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?

Detalles Bibliográficos
Autores principales: Quach, Stefanie, Holzgreve, Adrien, von Baumgarten, Louisa, Niyazi, Maximilian, Unterrainer, Marcus, Thon, Niklas, Stöcklein, Sophia, Bartenstein, Peter, Tonn, Jörg-Christian, Albert, Nathalie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525328/
https://www.ncbi.nlm.nih.gov/pubmed/35610517
http://dx.doi.org/10.1007/s00259-022-05844-3
_version_ 1784800681960407040
author Quach, Stefanie
Holzgreve, Adrien
von Baumgarten, Louisa
Niyazi, Maximilian
Unterrainer, Marcus
Thon, Niklas
Stöcklein, Sophia
Bartenstein, Peter
Tonn, Jörg-Christian
Albert, Nathalie L.
author_facet Quach, Stefanie
Holzgreve, Adrien
von Baumgarten, Louisa
Niyazi, Maximilian
Unterrainer, Marcus
Thon, Niklas
Stöcklein, Sophia
Bartenstein, Peter
Tonn, Jörg-Christian
Albert, Nathalie L.
author_sort Quach, Stefanie
collection PubMed
description
format Online
Article
Text
id pubmed-9525328
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95253282022-10-02 Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation? Quach, Stefanie Holzgreve, Adrien von Baumgarten, Louisa Niyazi, Maximilian Unterrainer, Marcus Thon, Niklas Stöcklein, Sophia Bartenstein, Peter Tonn, Jörg-Christian Albert, Nathalie L. Eur J Nucl Med Mol Imaging Image of the Month Springer Berlin Heidelberg 2022-05-25 2022 /pmc/articles/PMC9525328/ /pubmed/35610517 http://dx.doi.org/10.1007/s00259-022-05844-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Image of the Month
Quach, Stefanie
Holzgreve, Adrien
von Baumgarten, Louisa
Niyazi, Maximilian
Unterrainer, Marcus
Thon, Niklas
Stöcklein, Sophia
Bartenstein, Peter
Tonn, Jörg-Christian
Albert, Nathalie L.
Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
title Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
title_full Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
title_fullStr Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
title_full_unstemmed Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
title_short Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
title_sort increased tspo pet signal after radiochemotherapy in idh-wildtype glioma—indicator for treatment-induced immune activation?
topic Image of the Month
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525328/
https://www.ncbi.nlm.nih.gov/pubmed/35610517
http://dx.doi.org/10.1007/s00259-022-05844-3
work_keys_str_mv AT quachstefanie increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT holzgreveadrien increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT vonbaumgartenlouisa increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT niyazimaximilian increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT unterrainermarcus increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT thonniklas increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT stockleinsophia increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT bartensteinpeter increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT tonnjorgchristian increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation
AT albertnathaliel increasedtspopetsignalafterradiochemotherapyinidhwildtypegliomaindicatorfortreatmentinducedimmuneactivation